Stay updated on CYT-0851 in B-Cell Cancers & Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the CYT-0851 in B-Cell Cancers & Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CYT-0851 in B-Cell Cancers & Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page displays the completed CYT-0851 Phase 1/2 trial record, with its study design, eligibility criteria, outcomes, locations, and record dates, rather than a 403 error.
    Difference
    99%
    Check dated 2026-11-09T12:55:56.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now identifies the software revision as v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-02T12:24:17.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide notice announces updates to NIH terminology, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-26T13:41:02.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2, while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T13:48:07.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:34:31.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Access to the study record now shows a 403 Forbidden error page, replacing the study details with an error screen and standard site navigation. This change represents an access restriction rather than a substantive update to the study content.
    Difference
    23%
    Check dated 2026-09-21T21:00:21.000Z thumbnail image

Stay in the know with updates to CYT-0851 in B-Cell Cancers & Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CYT-0851 in B-Cell Cancers & Solid Tumors Clinical Trial page.